Where do Bristol-Myers Squibb's ratios come from?

Every ratio is computed from Bristol-Myers Squibb's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	281.3%-15.8pp	297.1%-10.4pp	307.5%-8.1pp	315.6%+9.8pp
Net margin	48.7%+110pp	-61.5%-131pp	69.8%+14.5pp	55.3%+78.1pp
EBITDA margin	110.8%+85.0pp	25.7%-138pp	164.1%+10.0pp	154.1%+68.9pp
Free cash flow margin	116.5%+3.3pp	113.3%+11.3pp	102%-13.6pp	115.6%-6.4pp
Returns
Return on equity	134.4%+257pp	-123%-224pp	101.1%+26.0pp	75.1%+94.6pp
Return on assets	24.8%+55.6pp	-30.8%-63.5pp	32.7%+8.1pp	24.6%+32.4pp
Return on invested capital	40.2%+85.9pp	-45.6%-101pp	55%+9.9pp	45%+50.2pp
Efficiency
Asset turnover	2×0.0×	2×+0.1×	1.9×+0.1×	1.8×+0.3×
Inventory turnover	20×-3.4×	23.4×-28.0×	51.4×-0.7×	52.1×+11.2×
Liquidity
Current ratio	5×+0.2×	4.8×-0.7×	5.4×0.0×	5.4×-0.7×
Quick ratio	4.6×+0.3×	4.3×-0.9×	5.2×-0.1×	5.3×-0.6×
Cash ratio	1.9×+0.5×	1.4×-0.3×	1.7×-0.2×	1.9×-0.6×
Leverage
Debt-to-equity	10.9×-1.6×	12.5×+7.3×	5.2×-0.1×	5.3×+0.3×
Debt-to-assets	2.1×-0.1×	2.2×+0.5×	1.7×0.0×	1.7×0.0×
Net debt / EBITDA	11×-65.2×	76.2×+69.5×	6.6×-0.6×	7.2×-10.2×
Valuation
Market capitalization	$421.42B+1.9%	$413.46B-18.3%	$505.78B-18.9%	$623.91B+11.8%
Enterprise value	$567.6B-3.7%	$589.13B-6.3%	$629.01B-16.5%	$753.52B+8.8%
Price / earnings	73.4×—	——	64.5×-32.1×	96.5×—
Price / sales	8.8×0.0×	8.8×-2.4×	11.2×-2.2×	13.3×+0.9×
Price / book	23.5×-1.2×	24.7×+8.2×	16.5×-3.0×	19.5×+4.4×
EV / EBITDA	42.7×-226×	268.2×+234×	33.9×-8.0×	41.8×-46.7×
EV / sales	11.9×-0.7×	12.6×-1.3×	13.9×-2.2×	16.1×+0.6×
Free cash flow yield	54.1%+2.0pp	52.1%+14.8pp	37.3%+2.7pp	34.7%-4.7pp
Earnings yield	22.4%+50.6pp	-28.2%-53.6pp	25.5%+8.9pp	16.6%+23.5pp
Dividend yield	19.2%+0.3pp	18.8%+3.7pp	15.1%+3.4pp	11.7%-0.6pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Bristol-Myers Squibb.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Bristol-Myers Squibb's ratios come from?: Every ratio is computed from Bristol-Myers Squibb's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.